About Mitoguardin 1
Mitoguardin 1 (MIGA1) is a protein
from Homo sapiens identified by UniProt accession
Q8NAN2, 632 residues long.
MolForge cross-references it against 0 known binders and
60 disease associations.
Target properties
| Protein name | Mitoguardin 1 |
| UniProt accession | Q8NAN2 |
| Gene | MIGA1 |
| Organism | Homo sapiens |
| Length | 632 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (60)
Diseases linked to this target (Open Targets).
- calcium measurement · score 0.37
- smoking initiation · score 0.29
- body height · score 0.17
- vital capacity · score 0.15
- body mass index · score 0.12
- physical activity measurement · score 0.12
- reticulocyte count · score 0.10
- birth weight · score 0.10
- platelet count · score 0.10
- electrocardiography · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NAN2-F1 | alphafold | PREDICTED | 64.06 | — |
Amino-acid sequence (632 residues)
MSDCCSAPGI SWEAGVGRPA VPGLELQIRR GAMSEETVSE SQFSLKTAAL RVFDLPLTWY YSLSQIKFSP VAKKLFVVTA VSAISVIFLA HHFKRKRGKK KGKILPWEPE HLILEYTKRA ASDKGSSCSS SRQNLTLSLS STKDKGSQVC NYANGGLFSK YSGSAQSLAS VQSVNSCHSC ACGNSNSWDK ADEDDIKLVN IPVTTPENLY LMGMELFEEA LRRWEQALTF RNRQAEDEAC GSIKLGAGDA IAEENVDDII STEFIHKLEA LLQRAYRLQE EFEATLGASD PNSLADDIDK DTDITMKGNV EDFGLRDTLS IASTDSFASA AELAEHREVR HTYSLESLCH CPFYEEAMHL VEEGKIYSRV LRTEMLECLG DSDFLAKLHC IRQAFQVILS ESANRIFLAE SGRKILSALI VKARKNPKKF EDVFDEMIYF LEQTDHWGST EMELAARGVK NLNFYDVVLD FILMDSFEDL ENPPTSIQNV VNNRWLNSSF KETAVASSCW SVLKQKRQQM KIPDGFFAHF YAICEHISPV LAWGFLGPRN SLYDLCCFFK NQVLLFLKDI FDFEKVRYSS TETLAEDLMQ LLIRRTELLM AYLEADALRH TSSCLSSHGH VMSTGLLEAK VQ
Explore Mitoguardin 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets